美股A股
StockGist
Back
8-K2026-03-12· grok-4-1-fast-non-reasoning

ATRA · Atara Biotherapeutics, Inc.

0001193125-26-103127

SEC filing

Summary

Atara Biotherapeutics, Inc. filed an 8-K on March 12, 2026, under Item 8.01 with Exhibit 99.1 being a press release dated March 12, 2026. No specific disclosure content or Item details beyond the filing structure are provided in the document.

Key takeaways